SUBSCRIBE
SUBSCRIBE
BioCapital

Drug Companies’ Overseas Operations Cause Tax Headaches

May 22, 2009 | 
1 min read

WSJ -- After entering a $3.4 billion settlement with the Internal Revenue Service in late 2006, GlaxoSmithKline is again tangling with the tax man, with some $1.9 billion at stake.

Asia Europe
MORE ON THIS TOPIC
A pill with the Amercan and Chinese flag wrapped around it
Government
FDA Freezes Trials Shipping Cells to China, ‘Other Hostile Countries’
June 20, 2025
 · 
2 min read
 · 
Tristan Manalac
3d illustration of a black dragon flying on an extraterrestrial world with mountains beneath.
Neuropsychiatric disorders
Draig Takes Flight With $140M Series A To Advance Neuropsych Drugs
June 18, 2025
 · 
2 min read
 · 
Tristan Manalac
Business concept illustration of a businessman digging and mining to find treasure
Antibody-drug conjugate (ADC)
NextCure Joins China-ADC Gold Rush with $745M Simcere Deal
June 16, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Pictured: European flags flap in the wind outside
Opinion
US Uncertainty Creates Clinical Trial Leadership Opportunity for Europe
June 16, 2025
 · 
6 min read
 · 
Craig Koch